Cargando…
Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas
Sialylated HEG1 has been reported as a highly specific and sensitive mesothelioma marker but a comprehensive evaluation of its expression in carcinomas in different organs, various sarcomas and reactive mesothelial proliferations has not been reported. The aim of this study was to evaluate the clini...
Autores principales: | Hiroshima, Kenzo, Wu, Di, Koh, Eitetsu, Sekine, Yasuo, Ozaki, Daisuke, Yusa, Toshikazu, Nakazawa, Tadao, Tsuji, Shoutaro, Miyagi, Yohei, Walts, Ann E., Marchevsky, Alberto M., Husain, Aliya N., Imai, Kohzoh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519072/ https://www.ncbi.nlm.nih.gov/pubmed/34240508 http://dx.doi.org/10.1111/pin.13140 |
Ejemplares similares
-
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma
por: Tsuji, Shoutaro, et al.
Publicado: (2017) -
Medical application of the monoclonal antibody SKM9-2 against sialylated HEG1, a new precision marker for malignant mesothelioma
por: TSUJI, Shoutaro, et al.
Publicado: (2023) -
Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1
por: Matsuura, Rieko, et al.
Publicado: (2018) -
A Biphasic Pleural Tumor with Features of an Epithelioid and Small Cell Mesothelioma: Morphologic and Molecular Findings
por: Hackman, Sarah, et al.
Publicado: (2016) -
Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma
por: Tada, Yuji, et al.
Publicado: (2020)